跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
RIVA-DORZOLAMIDE - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
RIVA-DORZOLAMIDE
Authorized
STANDARD
RIVA-DORZOLAMIDE
laboratoire riva inc.
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
81fca4ad5dbd81d0
Company
laboratoire riva inc.
Type
Standard
Approval Details
Approval Id
81fca4ad5dbd81d0
Drug Approval Canada Name
RIVA-DORZOLAMIDE
Product Name
RIVA-DORZOLAMIDE
Status
Cancelled Post Market
Status Date
2018-10-30
Original Market Date
2017-01-03
Din
02459345
Drug Class
Human
Dosage Form
Solution
Route Of Administration
Ophthalmic
Schedule
Prescription
Ahfs
52:40.12
Atc Original
S01EC03 DORZOLAMIDE
Atc Name
s 01 ec 03
Aig Number
0128558001
Company Name
laboratoire riva inc.
Company Address
660 Boul. Industriel, Blainville, Quebec, Canada, J7C 3V4
Active Ingredients
DORZOLAMIDE (DORZOLAMIDE HYDROCHLORIDE)
2 % / W/V
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
81fca4ad5dbd81d0
Type
Standard
Back to Health Canada Approvals